Joanne Estojak

Title: Joanne Estojak: Innovator in Cellular Morphological Research

Introduction

Joanne Estojak is a prominent inventor based in Jenkintown, PA (US). She has made significant contributions to the field of cellular biology, particularly in understanding the mechanisms that regulate cellular morphological alterations. With a total of 4 patents to her name, her work has implications for both research and therapeutic applications.

Latest Patents

One of her latest patents is focused on a signal mediator protein that induces cellular morphological alterations. This invention provides an isolated nucleic acid molecule that encodes a mammalian signal mediator protein involved in regulating these alterations. The encoded protein features an amino-terminal SH3 domain, an internal domain with several SH2 binding motifs, and a carboxy-terminal effector domain capable of inducing pseudohyphal budding in yeast. The invention also includes the novel signal mediator protein and antibodies specific to it. These biological molecules serve as valuable research tools and diagnostic agents for identifying and regulating complex signaling events that lead to morphological, potentially neoplastic, cellular changes.

Career Highlights

Joanne Estojak is affiliated with the Fox Chase Cancer Center, where she continues her research and innovation in cellular biology. Her work has garnered attention for its potential applications in cancer research and treatment.

Collaborations

Some of her notable coworkers include Erica A. Golemis and Susan F. Law, who contribute to the collaborative environment at the Fox Chase Cancer Center.

Conclusion

Joanne Estojak's innovative work in the field of cellular biology highlights her role as a key inventor in understanding and manipulating cellular processes. Her patents and research have the potential to advance both scientific knowledge and therapeutic strategies.